Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same

Details for Australian Patent Application No. 2004260695 (hide)

Owner Board of Regents, The University of Texas System

Inventors Dial, Elizabeth J.; Lichtenberger, Lenard M.

Agent FB Rice

Pub. Number AU-B-2004260695

PCT Pub. Number WO2005/011600

Priority 60/491,568 31.07.03 US

Filing date 2 August 2004

Wipo publication date 10 February 2005

Acceptance publication date 16 August 2007

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/011600 Priority application(s): WO2005/011600

30 March 2006 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from The Board of Regents of the University of Texas System to Board of Regents, The University of Texas System

16 August 2007 Application Accepted

  Published as AU-B-2004260695

13 December 2007 Standard Patent Sealed

7 August 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Jul 2008. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2005

11 December 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Jul 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260696-Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers

2004260689-Compounds and compositions as protein kinase inhibitors